Edward Miller

CIK 1619252 · General Counsel · last filed 2025-02-24

Edward Miller is a General Counsel who has filed 40 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing shows the insider sold $1.1K of ALVR on Feb 24, 2025. Across all open-market trades the lifetime net is −$296.7K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

40

Lifetime Open-Market Net

-$296.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Kalaris Therapeutics, Inc. (ALVR) Delisted General Counsel 21,575 $9.81 $211.7K -$296.7K 32 2025-02-24

Recent Filings

40 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-02-24 Kalaris Therapeutics, Inc. (ALVR) Delisted Sell (S) −106 -$1.1K EDGAR
2025-01-27 Kalaris Therapeutics, Inc. (ALVR) Delisted Sell (S) −52 -$494 EDGAR
2025-01-13 Kalaris Therapeutics, Inc. (ALVR) Delisted Sell (S) −409 -$180 EDGAR
2024-12-11 Kalaris Therapeutics, Inc. (ALVR) Delisted Gift (G) $0 EDGAR
2024-11-20 Kalaris Therapeutics, Inc. (ALVR) Delisted Sell (S) −432 -$237 EDGAR
2024-11-06 Kalaris Therapeutics, Inc. (ALVR) Delisted Sell (S) −2,272 -$2.0K EDGAR
2024-10-23 Kalaris Therapeutics, Inc. (ALVR) Delisted Sell (S) −1,401 -$1.1K EDGAR
2024-10-04 Kalaris Therapeutics, Inc. (ALVR) Delisted Sell (S) −377 -$307 EDGAR
2024-08-20 Kalaris Therapeutics, Inc. (ALVR) Delisted Sell (S) −422 -$321 EDGAR
2024-08-07 Kalaris Therapeutics, Inc. (ALVR) Delisted Sell (S) −2,323 -$1.7K EDGAR
Showing 110 of 40
Page 1 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.